Founder and clinical leader of the Regenix Group. Sets the company's long-term scientific direction and regulatory engagement, and serves as the bridge between the Group's medical-doctor promoter network and the biosimilar mission.
The Board
Oversees clinical, regulatory and manufacturing operations across Regenix's biosimilar portfolio. Leads CDSCO engagement, dossier strategy and the international expansion roadmap.
Leads operations, manufacturing scale-up, supply chain and quality systems across the facility. Owns the day-to-day operational excellence that underpins every batch released.
Drives commercial strategy, partnerships and international market development. Leads engagement with distributors, licensees and tender markets across Regenix's 120+ target geographies.
Leads financial strategy, capital allocation, treasury and investor relations across the Regenix Group. Oversees audit, compliance and the financial planning that underwrites the company's growth roadmap.
For partnership, investor or media enquiries — get in touch via the corporate inbox.
Contact Regenix →